aluates Reports

$ 0.0

Automative

Global Diverticulitis Treatment Market Research Report 2024

Published Date: June 2024

Report Code: QYRE-Auto-38C12288

Global Diverticulitis Treatment Market Research Report 2022

BUY CHAPTERS

Global Diverticulitis Treatment Market Research Report 2024

Code: QYRE-Auto-38C12288

Report

June 2024

Pages:96

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Teva Pharmaceutical Industries Ltd

Abbott Laboratories

B. Braun Medical Inc.

GSK

Bayer HealthCare Pharmaceuticals Inc.

Roche Holding AG

Johnson & Johnson Services

Sucampo Pharmaceuticals, Inc.

Valeant Pharmaceuticals International Inc

Synergy Pharmaceuticals, Inc.

Ardelyx Inc

Astellas Pharma Inc

Novartis

Hikma Pharmaceuticals

Baxter International

G.D. Searle LLC

Diverticulitis Treatment Market

Diverticular disease and diverticulitis are related digestive conditions that affect the large intestine (colon). In diverticular disease, small bulges or pockets (diverticula) develop in the lining of the intestine. Diverticulitis is when these pockets become inflamed or infected.

The global Diverticulitis Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Diverticulitis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Diverticulitis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Diverticulitis Treatment in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Diverticulitis Treatment include Pfizer, G.D. Searle LLC, Teva Pharmaceutical Industries Ltd, Abbott Laboratories, B. Braun Medical Inc, GSK plc, Bayer HealthCare Pharmaceuticals Inc, Roche Holding AG and Johnson & Johnson Services, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Diverticulitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diverticulitis Treatment.

Report Scope

The Diverticulitis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diverticulitis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diverticulitis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Diverticulitis Treatment Market Report

Report Metric	Details
Report Name	Diverticulitis Treatment Market
Segment by Type	Drug Treatment Surgical Treatment Supportive Care Others
Segment by Application	Hospitals Clinics Diagnostic Centers Ambulatory Surgical Center Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, G.D. Searle LLC, Teva Pharmaceutical Industries Ltd, Abbott Laboratories, B. Braun Medical Inc, GSK plc, Bayer HealthCare Pharmaceuticals Inc, Roche Holding AG, Johnson & Johnson Services, Sucampo Pharmaceuticals Inc, Valeant Pharmaceuticals International Inc, Synergy Pharmaceuticals Inc, Ardelyx Inc, Astellas Pharma Inc, Novartis AG, Hikma Pharmaceuticals, Baxter International
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diverticulitis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Diverticulitis Treatment Market report?

Ans: The main players in the Diverticulitis Treatment Market are Pfizer, G.D. Searle LLC, Teva Pharmaceutical Industries Ltd, Abbott Laboratories, B. Braun Medical Inc, GSK plc, Bayer HealthCare Pharmaceuticals Inc, Roche Holding AG, Johnson & Johnson Services, Sucampo Pharmaceuticals Inc, Valeant Pharmaceuticals International Inc, Synergy Pharmaceuticals Inc, Ardelyx Inc, Astellas Pharma Inc, Novartis AG, Hikma Pharmaceuticals, Baxter International

What are the Application segmentation covered in the Diverticulitis Treatment Market report?

Ans: The Applications covered in the Diverticulitis Treatment Market report are Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Center, Others

What are the Type segmentation covered in the Diverticulitis Treatment Market report?

Ans: The Types covered in the Diverticulitis Treatment Market report are Drug Treatment, Surgical Treatment, Supportive Care, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diverticulitis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Drug Treatment

1.2.3 Surgical Treatment

1.2.4 Supportive Care

1.2.5 Others

1.3 Market by Application

1.3.1 Global Diverticulitis Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Diagnostic Centers

1.3.5 Ambulatory Surgical Center

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Diverticulitis Treatment Market Perspective (2019-2030)

2.2 Diverticulitis Treatment Growth Trends by Region

2.2.1 Global Diverticulitis Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Diverticulitis Treatment Historic Market Size by Region (2019-2024)

2.2.3 Diverticulitis Treatment Forecasted Market Size by Region (2025-2030)

2.3 Diverticulitis Treatment Market Dynamics

2.3.1 Diverticulitis Treatment Industry Trends

2.3.2 Diverticulitis Treatment Market Drivers

2.3.3 Diverticulitis Treatment Market Challenges

2.3.4 Diverticulitis Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Diverticulitis Treatment Players by Revenue

3.1.1 Global Top Diverticulitis Treatment Players by Revenue (2019-2024)

3.1.2 Global Diverticulitis Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Diverticulitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Diverticulitis Treatment Revenue

3.4 Global Diverticulitis Treatment Market Concentration Ratio

3.4.1 Global Diverticulitis Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diverticulitis Treatment Revenue in 2023

3.5 Diverticulitis Treatment Key Players Head office and Area Served

3.6 Key Players Diverticulitis Treatment Product Solution and Service

3.7 Date of Enter into Diverticulitis Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Diverticulitis Treatment Breakdown Data by Type

4.1 Global Diverticulitis Treatment Historic Market Size by Type (2019-2024)

4.2 Global Diverticulitis Treatment Forecasted Market Size by Type (2025-2030)

5 Diverticulitis Treatment Breakdown Data by Application

5.1 Global Diverticulitis Treatment Historic Market Size by Application (2019-2024)

5.2 Global Diverticulitis Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Diverticulitis Treatment Market Size (2019-2030)

6.2 North America Diverticulitis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Diverticulitis Treatment Market Size by Country (2019-2024)

6.4 North America Diverticulitis Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Diverticulitis Treatment Market Size (2019-2030)

7.2 Europe Diverticulitis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Diverticulitis Treatment Market Size by Country (2019-2024)

7.4 Europe Diverticulitis Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Diverticulitis Treatment Market Size (2019-2030)

8.2 Asia-Pacific Diverticulitis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Diverticulitis Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Diverticulitis Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Diverticulitis Treatment Market Size (2019-2030)

9.2 Latin America Diverticulitis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Diverticulitis Treatment Market Size by Country (2019-2024)

9.4 Latin America Diverticulitis Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Diverticulitis Treatment Market Size (2019-2030)

10.2 Middle East & Africa Diverticulitis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Diverticulitis Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Diverticulitis Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Diverticulitis Treatment Introduction

11.1.4 Pfizer Revenue in Diverticulitis Treatment Business (2019-2024)

11.1.5 Pfizer Recent Development

11.2 G.D. Searle LLC

11.2.1 G.D. Searle LLC Company Detail

11.2.2 G.D. Searle LLC Business Overview

11.2.3 G.D. Searle LLC Diverticulitis Treatment Introduction

11.2.4 G.D. Searle LLC Revenue in Diverticulitis Treatment Business (2019-2024)

11.2.5 G.D. Searle LLC Recent Development

11.3 Teva Pharmaceutical Industries Ltd

11.3.1 Teva Pharmaceutical Industries Ltd Company Detail

11.3.2 Teva Pharmaceutical Industries Ltd Business Overview

11.3.3 Teva Pharmaceutical Industries Ltd Diverticulitis Treatment Introduction

11.3.4 Teva Pharmaceutical Industries Ltd Revenue in Diverticulitis Treatment Business (2019-2024)

11.3.5 Teva Pharmaceutical Industries Ltd Recent Development

11.4 Abbott Laboratories

11.4.1 Abbott Laboratories Company Detail

11.4.2 Abbott Laboratories Business Overview

11.4.3 Abbott Laboratories Diverticulitis Treatment Introduction

11.4.4 Abbott Laboratories Revenue in Diverticulitis Treatment Business (2019-2024)

11.4.5 Abbott Laboratories Recent Development

11.5 B. Braun Medical Inc

11.5.1 B. Braun Medical Inc Company Detail

11.5.2 B. Braun Medical Inc Business Overview

11.5.3 B. Braun Medical Inc Diverticulitis Treatment Introduction

11.5.4 B. Braun Medical Inc Revenue in Diverticulitis Treatment Business (2019-2024)

11.5.5 B. Braun Medical Inc Recent Development

11.6 GSK plc

11.6.1 GSK plc Company Detail

11.6.2 GSK plc Business Overview

11.6.3 GSK plc Diverticulitis Treatment Introduction

11.6.4 GSK plc Revenue in Diverticulitis Treatment Business (2019-2024)

11.6.5 GSK plc Recent Development

11.7 Bayer HealthCare Pharmaceuticals Inc

11.7.1 Bayer HealthCare Pharmaceuticals Inc Company Detail

11.7.2 Bayer HealthCare Pharmaceuticals Inc Business Overview

11.7.3 Bayer HealthCare Pharmaceuticals Inc Diverticulitis Treatment Introduction

11.7.4 Bayer HealthCare Pharmaceuticals Inc Revenue in Diverticulitis Treatment Business (2019-2024)

11.7.5 Bayer HealthCare Pharmaceuticals Inc Recent Development

11.8 Roche Holding AG

11.8.1 Roche Holding AG Company Detail

11.8.2 Roche Holding AG Business Overview

11.8.3 Roche Holding AG Diverticulitis Treatment Introduction

11.8.4 Roche Holding AG Revenue in Diverticulitis Treatment Business (2019-2024)

11.8.5 Roche Holding AG Recent Development

11.9 Johnson & Johnson Services

11.9.1 Johnson & Johnson Services Company Detail

11.9.2 Johnson & Johnson Services Business Overview

11.9.3 Johnson & Johnson Services Diverticulitis Treatment Introduction

11.9.4 Johnson & Johnson Services Revenue in Diverticulitis Treatment Business (2019-2024)

11.9.5 Johnson & Johnson Services Recent Development

11.10 Sucampo Pharmaceuticals Inc

11.10.1 Sucampo Pharmaceuticals Inc Company Detail

11.10.2 Sucampo Pharmaceuticals Inc Business Overview

11.10.3 Sucampo Pharmaceuticals Inc Diverticulitis Treatment Introduction

11.10.4 Sucampo Pharmaceuticals Inc Revenue in Diverticulitis Treatment Business (2019-2024)

11.10.5 Sucampo Pharmaceuticals Inc Recent Development

11.11 Valeant Pharmaceuticals International Inc

11.11.1 Valeant Pharmaceuticals International Inc Company Detail

11.11.2 Valeant Pharmaceuticals International Inc Business Overview

11.11.3 Valeant Pharmaceuticals International Inc Diverticulitis Treatment Introduction

11.11.4 Valeant Pharmaceuticals International Inc Revenue in Diverticulitis Treatment Business (2019-2024)

11.11.5 Valeant Pharmaceuticals International Inc Recent Development

11.12 Synergy Pharmaceuticals Inc

11.12.1 Synergy Pharmaceuticals Inc Company Detail

11.12.2 Synergy Pharmaceuticals Inc Business Overview

11.12.3 Synergy Pharmaceuticals Inc Diverticulitis Treatment Introduction

11.12.4 Synergy Pharmaceuticals Inc Revenue in Diverticulitis Treatment Business (2019-2024)

11.12.5 Synergy Pharmaceuticals Inc Recent Development

11.13 Ardelyx Inc

11.13.1 Ardelyx Inc Company Detail

11.13.2 Ardelyx Inc Business Overview

11.13.3 Ardelyx Inc Diverticulitis Treatment Introduction

11.13.4 Ardelyx Inc Revenue in Diverticulitis Treatment Business (2019-2024)

11.13.5 Ardelyx Inc Recent Development

11.14 Astellas Pharma Inc

11.14.1 Astellas Pharma Inc Company Detail

11.14.2 Astellas Pharma Inc Business Overview

11.14.3 Astellas Pharma Inc Diverticulitis Treatment Introduction

11.14.4 Astellas Pharma Inc Revenue in Diverticulitis Treatment Business (2019-2024)

11.14.5 Astellas Pharma Inc Recent Development

11.15 Novartis AG

11.15.1 Novartis AG Company Detail

11.15.2 Novartis AG Business Overview

11.15.3 Novartis AG Diverticulitis Treatment Introduction

11.15.4 Novartis AG Revenue in Diverticulitis Treatment Business (2019-2024)

11.15.5 Novartis AG Recent Development

11.16 Hikma Pharmaceuticals

11.16.1 Hikma Pharmaceuticals Company Detail

11.16.2 Hikma Pharmaceuticals Business Overview

11.16.3 Hikma Pharmaceuticals Diverticulitis Treatment Introduction

11.16.4 Hikma Pharmaceuticals Revenue in Diverticulitis Treatment Business (2019-2024)

11.16.5 Hikma Pharmaceuticals Recent Development

11.17 Baxter International

11.17.1 Baxter International Company Detail

11.17.2 Baxter International Business Overview

11.17.3 Baxter International Diverticulitis Treatment Introduction

11.17.4 Baxter International Revenue in Diverticulitis Treatment Business (2019-2024)

11.17.5 Baxter International Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

Teva Pharmaceutical Industries Ltd

Abbott Laboratories

B. Braun Medical Inc.

GSK

Bayer HealthCare Pharmaceuticals Inc.

Roche Holding AG

Johnson & Johnson Services

Sucampo Pharmaceuticals, Inc.

Valeant Pharmaceuticals International Inc

Synergy Pharmaceuticals, Inc.

Ardelyx Inc

Astellas Pharma Inc

Novartis

Hikma Pharmaceuticals

Baxter International

G.D. Searle LLC

List of Tables

Table 1. Global Diverticulitis Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Drug Treatment

Table 3. Key Players of Surgical Treatment

Table 4. Key Players of Supportive Care

Table 5. Key Players of Others

Table 6. Global Diverticulitis Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Diverticulitis Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Diverticulitis Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Diverticulitis Treatment Market Share by Region (2019-2024)

Table 10. Global Diverticulitis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Diverticulitis Treatment Market Share by Region (2025-2030)

Table 12. Diverticulitis Treatment Market Trends

Table 13. Diverticulitis Treatment Market Drivers

Table 14. Diverticulitis Treatment Market Challenges

Table 15. Diverticulitis Treatment Market Restraints

Table 16. Global Diverticulitis Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Diverticulitis Treatment Market Share by Players (2019-2024)

Table 18. Global Top Diverticulitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diverticulitis Treatment as of 2023)

Table 19. Ranking of Global Top Diverticulitis Treatment Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Diverticulitis Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Diverticulitis Treatment Product Solution and Service

Table 23. Date of Enter into Diverticulitis Treatment Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Diverticulitis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Diverticulitis Treatment Revenue Market Share by Type (2019-2024)

Table 27. Global Diverticulitis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Diverticulitis Treatment Revenue Market Share by Type (2025-2030)

Table 29. Global Diverticulitis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Diverticulitis Treatment Revenue Market Share by Application (2019-2024)

Table 31. Global Diverticulitis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Diverticulitis Treatment Revenue Market Share by Application (2025-2030)

Table 33. North America Diverticulitis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Diverticulitis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Diverticulitis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Diverticulitis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Diverticulitis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Diverticulitis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Diverticulitis Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Diverticulitis Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Diverticulitis Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Diverticulitis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Diverticulitis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Diverticulitis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Diverticulitis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Diverticulitis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Diverticulitis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 48. Pfizer Company Detail

Table 49. Pfizer Business Overview

Table 50. Pfizer Diverticulitis Treatment Product

Table 51. Pfizer Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 52. Pfizer Recent Development

Table 53. G.D. Searle LLC Company Detail

Table 54. G.D. Searle LLC Business Overview

Table 55. G.D. Searle LLC Diverticulitis Treatment Product

Table 56. G.D. Searle LLC Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 57. G.D. Searle LLC Recent Development

Table 58. Teva Pharmaceutical Industries Ltd Company Detail

Table 59. Teva Pharmaceutical Industries Ltd Business Overview

Table 60. Teva Pharmaceutical Industries Ltd Diverticulitis Treatment Product

Table 61. Teva Pharmaceutical Industries Ltd Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 62. Teva Pharmaceutical Industries Ltd Recent Development

Table 63. Abbott Laboratories Company Detail

Table 64. Abbott Laboratories Business Overview

Table 65. Abbott Laboratories Diverticulitis Treatment Product

Table 66. Abbott Laboratories Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 67. Abbott Laboratories Recent Development

Table 68. B. Braun Medical Inc Company Detail

Table 69. B. Braun Medical Inc Business Overview

Table 70. B. Braun Medical Inc Diverticulitis Treatment Product

Table 71. B. Braun Medical Inc Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 72. B. Braun Medical Inc Recent Development

Table 73. GSK plc Company Detail

Table 74. GSK plc Business Overview

Table 75. GSK plc Diverticulitis Treatment Product

Table 76. GSK plc Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 77. GSK plc Recent Development

Table 78. Bayer HealthCare Pharmaceuticals Inc Company Detail

Table 79. Bayer HealthCare Pharmaceuticals Inc Business Overview

Table 80. Bayer HealthCare Pharmaceuticals Inc Diverticulitis Treatment Product

Table 81. Bayer HealthCare Pharmaceuticals Inc Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 82. Bayer HealthCare Pharmaceuticals Inc Recent Development

Table 83. Roche Holding AG Company Detail

Table 84. Roche Holding AG Business Overview

Table 85. Roche Holding AG Diverticulitis Treatment Product

Table 86. Roche Holding AG Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 87. Roche Holding AG Recent Development

Table 88. Johnson & Johnson Services Company Detail

Table 89. Johnson & Johnson Services Business Overview

Table 90. Johnson & Johnson Services Diverticulitis Treatment Product

Table 91. Johnson & Johnson Services Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 92. Johnson & Johnson Services Recent Development

Table 93. Sucampo Pharmaceuticals Inc Company Detail

Table 94. Sucampo Pharmaceuticals Inc Business Overview

Table 95. Sucampo Pharmaceuticals Inc Diverticulitis Treatment Product

Table 96. Sucampo Pharmaceuticals Inc Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 97. Sucampo Pharmaceuticals Inc Recent Development

Table 98. Valeant Pharmaceuticals International Inc Company Detail

Table 99. Valeant Pharmaceuticals International Inc Business Overview

Table 100. Valeant Pharmaceuticals International Inc Diverticulitis Treatment Product

Table 101. Valeant Pharmaceuticals International Inc Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 102. Valeant Pharmaceuticals International Inc Recent Development

Table 103. Synergy Pharmaceuticals Inc Company Detail

Table 104. Synergy Pharmaceuticals Inc Business Overview

Table 105. Synergy Pharmaceuticals Inc Diverticulitis Treatment Product

Table 106. Synergy Pharmaceuticals Inc Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 107. Synergy Pharmaceuticals Inc Recent Development

Table 108. Ardelyx Inc Company Detail

Table 109. Ardelyx Inc Business Overview

Table 110. Ardelyx Inc Diverticulitis Treatment Product

Table 111. Ardelyx Inc Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 112. Ardelyx Inc Recent Development

Table 113. Astellas Pharma Inc Company Detail

Table 114. Astellas Pharma Inc Business Overview

Table 115. Astellas Pharma Inc Diverticulitis Treatment Product

Table 116. Astellas Pharma Inc Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 117. Astellas Pharma Inc Recent Development

Table 118. Novartis AG Company Detail

Table 119. Novartis AG Business Overview

Table 120. Novartis AG Diverticulitis Treatment Product

Table 121. Novartis AG Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 122. Novartis AG Recent Development

Table 123. Hikma Pharmaceuticals Company Detail

Table 124. Hikma Pharmaceuticals Business Overview

Table 125. Hikma Pharmaceuticals Diverticulitis Treatment Product

Table 126. Hikma Pharmaceuticals Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 127. Hikma Pharmaceuticals Recent Development

Table 128. Baxter International Company Detail

Table 129. Baxter International Business Overview

Table 130. Baxter International Diverticulitis Treatment Product

Table 131. Baxter International Revenue in Diverticulitis Treatment Business (2019-2024) & (US$ Million)

Table 132. Baxter International Recent Development

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Diverticulitis Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Diverticulitis Treatment Market Share by Type: 2023 VS 2030

Figure 3. Drug Treatment Features

Figure 4. Surgical Treatment Features

Figure 5. Supportive Care Features

Figure 6. Others Features

Figure 7. Global Diverticulitis Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Diverticulitis Treatment Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Diagnostic Centers Case Studies

Figure 12. Ambulatory Surgical Center Case Studies

Figure 13. Others Case Studies

Figure 14. Diverticulitis Treatment Report Years Considered

Figure 15. Global Diverticulitis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Diverticulitis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Diverticulitis Treatment Market Share by Region: 2023 VS 2030

Figure 18. Global Diverticulitis Treatment Market Share by Players in 2023

Figure 19. Global Top Diverticulitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diverticulitis Treatment as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Diverticulitis Treatment Revenue in 2023

Figure 21. North America Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Diverticulitis Treatment Market Share by Country (2019-2030)

Figure 23. United States Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Diverticulitis Treatment Market Share by Country (2019-2030)

Figure 27. Germany Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Diverticulitis Treatment Market Share by Region (2019-2030)

Figure 35. China Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Diverticulitis Treatment Market Share by Country (2019-2030)

Figure 43. Mexico Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Diverticulitis Treatment Market Share by Country (2019-2030)

Figure 47. Turkey Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Diverticulitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Pfizer Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 50. G.D. Searle LLC Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 51. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 52. Abbott Laboratories Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 53. B. Braun Medical Inc Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 54. GSK plc Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 55. Bayer HealthCare Pharmaceuticals Inc Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 56. Roche Holding AG Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 57. Johnson & Johnson Services Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 58. Sucampo Pharmaceuticals Inc Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 59. Valeant Pharmaceuticals International Inc Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 60. Synergy Pharmaceuticals Inc Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 61. Ardelyx Inc Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 62. Astellas Pharma Inc Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 63. Novartis AG Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 64. Hikma Pharmaceuticals Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 65. Baxter International Revenue Growth Rate in Diverticulitis Treatment Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Ulcerative Colitis Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Based Gastrointestinal Disorders Therapeutics Market Research Report 2024

Global Gastrointestinal Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Ulcerative Colitis Disease Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastrointestinal Drugs Market Research Report 2025

Global Gastrointestinal Therapeutics Market Research Report 2024

Global Appendicitis Market Insights Forecast to 2030

Global Biliary Tract Disorder Treatment Market Insights Forecast to 2030

Inflammatory Bowel Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prescription Gastrointestinal Drugs Market Research Report 2024

Pouchitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Irritable Bowel Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Crohn s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bacterial Enteric Disease Testing Market Research Report 2024

Global Hirschsprung Disease Treatment Market Research Report 2025

Irritable Bowel Syndrome Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Necrotic Enteritis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Crohn s Disease Market Research Report 2024

Anorectal Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions